Ciproquazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H18N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P8S0GE5Q4I, chemically known as 2(1h)-quinazolinone, 1-(cyclopropylmethyl)-6-methoxy-4-phenyl- but generally known as ciproquazone, which bears US NIH Compound Identifier 36489. European Medicines Agency schedules Ciproquazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07473MIG. The term CIPROQUAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CIPROQUAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciproquazone under HS 29335995 and SITC 51576. As of Q4 2014, CIPROQUAZONE remains the US FDA Preferred Term for this commodity. Ciproquazone bears US NLM identifiers UMLS ID C2347773 and NCI Concept Code C72114. SMILES: O=C1N(CC2CC2)C2C(C(N1)C1CCCCC1)CC(OC)CC2.